Article information
Full text is only aviable in PDF
References
[1.]
M. Beldner, M. Jacobson, G.E. Burges, D. Dewaay, J.C. Maize, U.B. Chaudhary.
Localized palmar-plantar epidermal hyperplasia: a previously undefined dermatologic toxicity to sorafenib.
Oncologist, 12 (2007), pp. 1178-1182
[2.]
C. Robert, J.C. Soria, A. Spatz, A. Le Cesne, D. Malka, P. Pautier, et al.
Cutaneous side-effects of kinase inhibitors and blocking antibodies.
Lancet Oncol, 6 (2005), pp. 491-500
[3.]
M.J. Ratain, T. Eisen, W.M. Stadler, K.T. Flaherty, S.B. Kaye, G.L. Rosner, et al.
Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma.
J Clin Oncol, 24 (2006), pp. 1-8
[4.]
N.M. Chung, M. Gutiérrez, M.L. Turner.
Leukocytoclastic vasculitis masquerading as hand-foot syndrome in a patient treated with sorafenib.
Arch Dermatol, 142 (2006), pp. 1510-1511
[5.]
J.L. MacGregor, D.N. Silvers, M.E. Grossman, W.H. Sherman.
Sorafenib-induced erythema multiforme.
J Am AcadDermatol, 56 (2007), pp. 527-528
[6.]
H.H. Kong, E.W. Cowen, N.S. Azad, W. Dahut, M. Gutiérrez, M.L. Turner.
Keratoacanthomas associated with sorafenib therapy.
J Am Acad Dermatol, 56 (2007), pp. 171-172
[7.]
A. Awada, A. Hendlisz, T. Gil, S. Bartholomeus, M. Mano, C. de Valeriola, et al.
Phase I safety and pharmacokinetics of BAY43-9006 administered for 21 days on/7 days off in patients with advanced, refractory solid tumors.
Br J Cancer, 92 (2005), pp. 1855-1861
[8.]
L. Hueso, O. Sanmartín, E. Nagore, R. Botella-Estrada, C. Requena, B. Llombart, et al.
Eritema acral inducido por quimioterapia: estudio clínico e histopatológico de 44 casos.
Actas Dermosifiliogr, 99 (2008), pp. 281-290
[9.]
K.B. Gordon, A. Tajuddin, J. Guitart, T.M. Kuzel, L.R. Eramo, J. VonRoenn.
Hand-food syndrome associated with liposome encapsulated doxorubicin therapy.
Cancer, 75 (1995), pp. 2169-2173
[10.]
D. Strumberg, A. Awada, H. Hirte, J.W. Clark, S. Seeber, P. Piccart, et al.
Pooled safety analysis of BAY 43-9006 (sorafenib) monotherapy in patients with advanced solid tumours: is rash associated with treatment outcome?.
Eur J Cancer, 42 (2006), pp. 548-556
Copyright © 2009. Academia Española de Dermatología y Venereología and Elsevier España, S.L.
